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Introduction
Glucosidases are enzymes abundant in the gastrointestinal (GI) tract, where they catalyze the final step of the carbohydrates digestion. This enzyme has drawn a great interest in the scientific community since the inhibition of the glucose absorption could be used to control the blood glucose level and for hypocaloric dietary regimen. Thus, an inhibitor of α-glucosidase may be used as therapeutic agent in the treatment of diabetes and obesity. However, due to its role in the metabolism of carbohydrates it has also been speculated to be useful in the management of other diseases in which the cell metabolism has a critical role, such as cancer, viral infection, hepatitis (Rutten et al., 2006) . Dietary patterns and body exercises are in the line for treatment of incipient type 2 diabetes mellitus (DM-T2) also defined as prediabetes. If this approach alone failed to lower the glucose concentration in the bloodstream, a medicinal approach should be recommended (Rutten et al., 2006) . 
Materials and Methods

Peptide Library Generation
The peptide library has been built in house, by a python program which generates all possible combinations of strings containing three letters among the 20 one-letter code of the amino acids. By this way, the program generated 20 3 novel combinations of tripeptides without protonation states, which became around 10000 after ligand preparation being included also alternative protonation states for some residues, e.g. for Histidines. These obtained strings database was converted in 3D chemical structures using Maestro molecular modeling suit (Schrödinger Release 2017 -4: Maestro, Schrödinger, LLC, New York, NY, 2017 . Then the peptide library needs to be prepared and manually amidated at the C-terminus.
Protein Preparation
The crystal structure of α-glucosidase (PDB ID, 3TOP) was obtained from the RCSB database (Shen, Qin, Ren, 2011 ; Joint Center for Structural Genomics, Crystal structure of Alpha-glucosidase (TM0752) from Thermotoga maritima at 2.50 A resolution RCSBPSP, (2004) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . This structure needs to be prepared by protein preparation wizard (Sastry, Adzhigirey, Day, Annabhimoju and Sherman, 2013) tool embedded in Maestro molecular modeling suite. The PropKa program was used to locate protonation states at the physiological pH of 7.4 (Olsson, Søndergaard, Rostkowski and Jensen, 2011) . Hydrogen atoms were added and minimized. In the raw pdb file, other molecules also present in the crystallization medium, these molecules have been removed.
Glide Docking of the co-crystallized ligand docking
In an early stage, we tested the suitability of Glide extra precision (XP) protocol to predict the ligand position of the reference compound (Friesner et al., 2006) . Co-crystallized inhibitor acarbose was prepared by the LigPrep module, and then it was docked to the active sites of α-glucosidase by Glide/XP protocol. The binding cavity was assigned as an outer box of size 25x 25 x25 Å, determined by the position of the crystallographic ligand. The RMSD value for acarbose was calculated by SID (simulation interface) and compared crystallized acarbose after XP docking and was found as less than 1.3 Å ( Figure 2 ). 
Peptide Library Docking
Docking experiments were performed by Glide (Friesner et al., 2006) . The grid to set up the docking was created with standard parameters optimized for peptide docking. The grid box coordinates were centered at the crystallographic ligand and a size of 25.0 Å of each side was assigned. The peptide library was prepared by LigPrep tool (Sastry et al., 2013) , the molecules ionized at a pH of 7.4 by Epik. The number of peptide ligands, including tautomers rise up to around 10000. The library was used after minimization by OPLS-3 ff without further modifications.
Virtual screening workflow
Docking with XP scoring method within Glide has been adopted to dock the library into the acarbose defined enzymatic pocket with the default parameters, and the best ranked 3300 (30% of the molecules giving a scoring value of at least -8.0 kcal/mol) ranking poses of each molecule were retained for the next step of hits enrichment, by Prime/MM-GSBA (Bell et al., 2012) . Finally, 20 ns molecular dynamic (MD) simulations were performed by using the docking poses of that compounds with the best free binding energy. The MD simulation trajectory analysis led us to identify the final hits for in vitro analysis. MD simulations allow to study the connections of the best ranked pose found by Glide and ranked by Prime, as well as to observe the time-dependent evolution of the interactions between ligand and enzyme, not detectable from the docking study only.
Prime/MM-GBSA
The top 30% of the poses obtained by docking od the entire library with Glide/XP scoring function were retained and submitted for MM/GBSA calculations performed with Prime module of Maestro. All the parameters were kept default. MM/GBSA is able to calculate the free binding energy of the complex ligand-enzyme in a water environment. The energy was estimated by the OPLS3 force field (Harder et al., 2016) for molecular mechanic energy (EMM) and the surface-generalized Born model (SGBM) for polar solvation energy (VSGB), and the apolar solvation factor (GSA). This energetic term is calculated for the complex, for the ligand and for the protein alone, then the binding free energy (ΔGbind) is finally obtained by the following equation:
The top-12 compounds ranked by the free binding energy returned by MM/GBSA experiments were submitted for MD ( Figure 3 ). 
Molecular Dynamics (MD) simulations
The docked tripeptide-enzyme poses were subjected to MD simulations in water (Hospital, Goñi, Orozco and Gelpì, 2015) . Desmond has been employed for the simulations. The complex was inserted in aqueous environment. The model constitutes of a box of water in which is inserted the complex. The box has a minimum size as to contain the complex ensuring a distance of 10 Å from the edge of the box and the protein. In order to neutralize the system, 0.15 M NaCl has been added to the system. The OPLS3 ff was used for all the experiments. TIP3P-TIP4P model (Penna and Lennart, 2001 ) was used water. The system was minimized up to 2000 steps, holding all the protein and ligand atoms. The minimized system was subjected to MD simulations, using the NPT ensemble and periodic boundary conditions for 20 ns. To control the pressure Martyna-Tobias-Klein method was used which allows to keep the pressure of the system at 1.01 bar by using the isotropic coupling method. The Nose-Hoover thermostat was applied to control the temperature at 310K. The trajectories and other parameters were saved every 20 and 1.2 ps respectively to returns 1000 frames. The simulation analysis was done by the simulation interactive diagram (SID), especially useful to visualize the RMSD fluctuations of ligand and enzyme, hydrogen bonds stability, rotation of groups on the ligand, van der Waals interactions over the simulation trajectories and overall stability of the secondary structure of the enzyme.
MetaCore/MetaDrug Applications
1.
The hit molecules obtained from docking and MD simulations protocol were evaluated for the investigation of their therapeutic activity, pharmacokinetic and toxicity properties by using MetaCore/MetaDrug comprehensive systems biology analysis suite of Clarivate Analytics with the help of available ADME, disease and toxicity QSAR models (Mollica, Costante, Akdemirb et al., 2015) . MetaCore is based on a high-quality, manually-curated database of molecular interactions, molecular pathways, gene-disease associations, chemical metabolism and toxicity information. The hit molecules obtained from virtual screening were tested for their biological effects as potential AGI candidates. Furthermore, various toxic effects such as mutagenecity, anemia, carcinogenicity, cardiotoxicity, cytotoxicity, epididymis toxicity, genotoxicity, hepatotoxicity, kidney necrosis, kidney growth, liver 
Chemistry
Synthesis of compounds
The synthesis of compounds 1-4 was performed by solid phase peptide synthesis (SPPS) (Mollica, Pinnen, Stefanucci and Costante, 2013; Mollica, Costante, Novellino et al., 2015) ( Table 1 ). The N terminus protecting group was Fmoc, the protection group of the side chains of the amino acids were tert-butyloxy-carbonyl for Lysine and Tryptophan, Pbf for Arginine, Trityl for Asn. We used Rink amide resin with a 1.2 mMol/g loading, to obtain amidates peptides at the C terminus, the system TBTU/HOBt/DIPEA was used as coupling mixture and piperidine 20% in DMF for Fmoc group deprotection as previously reported by our group (Scheme 1). Purification via RP-HPLC afforded the desired peptides in excellent yields. Peptides were characterized by 1 H NMR and Ms spectrometer.
Materials and Methods
Solvents and reagents were purchased from WVR (Italy) and used as supplied without further purification. Amino acids were purchased from GLS Shanghai (China). 1 H NMR spectra were recorded at 25° C on a 300 MHz Varian Mercury spectrometer. Chemical shifts are reported in parts per million (δ) downfield from the internal standard TMS. Mass spectra were recorded on a LCQ Finnigan-Mat mass spectrometer (San Jose, CA) by ESI-spay source and ion trap analyzer. The capillary temperature was set at 200 °C and the spray voltage at 4.00 kV. The electropray was formed by using nitrogen (N2) as both the sheath gas and the auxiliary gas with a flow of elium. The purity of final TFA salts was confirmed by NMR analysis, ESI-LRMS, and analytical RP-HPLC recorded at 216, 235 254, and 275 nm (Waters C18 4.6 mm × 150 mm) at a flow rate of 1 mL/min, using as eluent a gradient of H2O/acetonitrile−0.1% TFA ranging from 5% ACN to 90% ACN in 32 minutes, and was found to be≥96%.
Synthesis
Resin loading
The Rink Amid Fmoc resin was deprotected by 20% piperidine in DMF (2 × 15 min). The resin was flush washed by treatment with MeOH/DMF/DCM repeated three times each. The first amino acid to load (3 equiv) is dissolved in a flask in DMF (5 mL), then TBTU (3 equiv) and DIPEA (6 equiv) were added and the resulting mixture was shaked for 10 minutes, then added to the resin. The coupling was kept shacked vigorously overnight. Kaiser test was routinely used to check the coupling. After competition, the resin was flush washed with MeOH/DMF/DCM three times each.
Cleavage and purification
In order to cleave the peptide from the resin, a mixture of TFA/H2O/TIPS 95:2.5:2.5 (8 mL for 1 h) was added to the plastic vessel and shacked for 2.5 hours. After this time the solution is collected, concentrated under vacuum and the resulting ˜1 mL of solution, that was precipitated in cold ether. The peptide was separated from the solution by centrifugation at 4000 rpm for 5 minutes, and the ether removed. This process war repeated four times, the obtained solid was then dried at reduced pressure.
Final peptides 1-4 were purified by HPLC using a Waters XBridge semiprep C18, 5.0 μm, 250 mm× 10 mm column at a flow rate of 4 mL/min on a Waters pump 600, using as eluent a linear gradient of H2O+0.1% TFA/ACN+0.1% TFA, from 5% ACN to 90% ACN in 32 min. 
Enzyme Assay
α-glucosidase inhibition
The four peptides 1-4 were tested for inhibition of α-glucosidase as previously reported by our research group (Zengin, 2016) (Table 2 ). Compound solution (50 µL) was mixed with GSH (50 µL), αglucosidase stock (from Saccharomyces cerevisiae, EC 3.2.1.20, Sigma) (50 µL) in buffer (phosphate, pH 6.8) and PNPG (4-N-trophenyl-α-D-glucopyranoside) (50 µL) in a 96-well microplate and incubated for 15 min at 37 °C. Similarly, a blank was prepared by adding compound solution to all reaction reagents without enzyme (α-glucosidase) solution. The reaction was then stopped with the addition of Na2CO3 (50 µL, 0.2 M). The sample and blank absorbances were read at 400 nm. The absorbance of the blank was subtracted from that of the sample inhibitory activity of each compounds on α-glucosidase activity was calculated as equivalents of acarbose. 
Results and discussion
VS on glucosidase has been proved to be a valuable tool to find new lead compounds (Sanders et al., 2012) . To discover novel inhibitor candidates of α-glucosidase, a virtual peptide library was generated in house and screened in silico. The virtual screening was carried out into three steps, firstly all the ligands were screened by docking performed by Glide/XP scoring function (Halgren et al., 2004) . In a second step, around 30% of the ligands with high-docking score have been retained for MM/GBSA re-scoring. The top-10 hits were retained for MD simulations. After RMSD analysis, four peptides have been selected for synthesis by SPPS methodology and tested by in vitro analysis in order to validate the virtual screening results. In vitro analysis showed that compounds 1-4 inhibited α-glucosidase with an inhibitory potency calculated in equivalents of acarbose reported in Table 2 . Compound 2 was found to be the most active among this series. Several papers deal with the developing of suitable computational methods of scoring accurately the molecules contained in virtual libraries generally composed of 'small molecules' (Sliwoski, Kothiwale, Meiler and Lowe, 2014) ; however, at the best of our knowledge this is the first attempt to use a combinatorial peptides' library for a virtual screening. We used Glide/XP to produce the docking poses, as it was found to be able to reproduce the pose of the crystallographic ligand acarbose, and the best 30% compounds were used for rescoring by MM/GBSA, which in several papers is reported to be one of the most reliable method of rescoring the hits after docking. Prime/MM-GBSA has been applied taking in consideration its good performance to rank the potential ligands better than Glide. This quality has been validated in several targets, which is probably due to its realistic parametrization of the solvation that occurs to the complex in water. The satisfactory combination of Glide to generate reliable binding poses joined to accuracy of Prime in the calculation of the free binding energy produced 12 best hits, that were reduced to four after MD simulations. As illustrated in Figure 4 , the four inhibitor candidates have similar predicted docking poses in the binding to -glucosidase ( Figure 1A) , and their highly flexible structures, fit well into the acarbose-binding pocket, due to a similarity in steric and electronic distribution. The potency of the novel AGIs was in micro-molar range, however none of the compounds reached the docking score and MM/GBSA calculated for acarbose, in agreement with the activity observed for the four peptides (the most active peptide (2) has an activity equal to 0.7 equivalents of acarbose). The crystallographic ligand acarbose interacts with α-glucosidase in the enzymatic cavity by establishing several hydrogen-bond (H-bond) interactions. In particular, the key interactions involve: Asp1157, Asp1279, Lys1460, Arg1510, Asp1526, His1584. The peptide inhibitors contain several hydrophilic groups, such as the amide and amine groups, which may mimicry the polar interactions with the polar region of the binding site in a similar way of acarbose. However, not all H-bond interactions made by acarbose are respected, such as for the H-bond toward Arg1510, His1584 that were not observed for compounds 2 and 3. All the tested peptides (compounds 1-4) share the following interactions: Asp1157, Asp1279, Asp1526. Peptide 4 has also in common with acarbose the H-bond to Lys1460, whereas the compounds 1 and 2 do not display this H bond but interact to the same residue by establishing a π-cation interaction. Peptide 3 does not interact with Lys1460 residue but forms a πcation interaction with Phe1559. Moreover, all the selected compounds have further interaction to Tyr1251 (π -cation), Asp1420 (ionic for 2 and 3 and H-bond for 1 and 4) , Thr1586 (H-bond). Peptide 2 which has shown the best activity, may provide a starting lead structure for further optimizations as selective inhibitor. The observed preferential inhibition of the compound 2 also provides helpful information about the preferential binding mode and key interactions. The best pose found for 2 indeed showed the presence of a folded motif, namely a -turn inverse turn (Guruprasad and Rajkumar, 2000; Mollica et al., 2006; Aschi et al., 2003; Morera et al., 2005; Durdagi et al., 2013) , centered at the lysine residues and stabilized by the intramolecular H-bond formed with the interaction of the carbonyl oxygen of the Trp residue (i) and the proton of the amide group of the alanine residue (i+2) Figure 5 . 
MetaCore/MetaDrug Applications
When Tables 3-5 are examined it can be seen that selected peptides can have some therapeutic potentials (cut-off value for therapeutic potential is 0.5). The values in brackets in this table is Tanimato Prioritization (TP). A maximal Tanimato coefficient calculated for all molecules in a training set of a QSAR model indicates similarity of the analyzed structure to the most similar compound in the training set. The high docking scores and the acceptability of the values of therapeutic activities alone may not be enough for the molecules we choose. Taking this into account we have investigated the ADME properties like BBB (blood brain barrier), G-log P (lipophilicity), Prot-bind, % (connectivity to blood serum proteins) and Prot-bind, log t (connectivity to blood serum albumin proteins). These parameters are very important for the candidate drug-like molecules ( Table 3) . ADME/QSAR models, therapeutic and toxicity prediction profiles of 4 peptides with positive control molecules are compared. Based on results, lipophilicity (log of compound octanol/water distribution) values of designed peptides are found high ( Table 4 , Table 5 ). Although blood brain barrier penetration of 4 peptides are smaller than cutoff value (-0.3), their values are similar/smaller than positive controls. Within the 4 peptides, peptides 1, 2 and 3 showed potential antidiabetic activities (Table 4 ). Table 3 . ADME QSAR Models.
ADME QSAR Models
1. Blood brain barrier penetration model. The data is expressed as log values of the ratio of the metabolite concentrations in brain and plasma. Cutoff is -0.3. Larger values indicate that the metabolite is more likely to enter the brain. 
Prediction of Therapeutic Activity
Peptide-1 Peptide-2 Peptide-3
Peptide-4 Acarbose Voglibose Miglitol
Allergy (1) Table 4 . Prediction of therapeutic activities. Liver Lipid Accumulation (16) Table 5 . Prediction of toxicity values.
Prediction of Toxic Effects
